Preview

Cancer Urology

Advanced search

Choice of urine derivation method after radical cystectomy in the high anesthesiological risk group

https://doi.org/10.17650/1726-9776-2020-16-1-90-98

Abstract

Background. Radical cystectomy is the standard treatment for muscle-invasive bladder cancer. Muscle invasion can occur in 48 % of patients. Epidemiologically, the peak incidence of bladder cancer is observed in men at the seventh decade of life. At the time of diagnosis, many of these patients have serious comorbidity. The trauma of radical cystectomy in combination with comorbidity creates an insurmountable barrier to radical treatment in a large part of patients. Refusal to use intestinal segments for urine diversion dramatically reduces the invasiveness of the intervention. However, the implementation of bilateral ureterocutaneostomy is associated with a greater frequency of pyelonephritis due to the use of external stents and scarring of the ureterocutaneostomy. A transureteroureterostomy with a unilateral ureterocutaneostomy can be a definite alternative.

Objective: to evaluate the effectiveness of cross ureteroureterostomy for urine derivation after radical cystectomy in patients with muscle-invasive bladder cancer and a high risk of perioperative complications.

Materials and methods. The article analyzes 28 cystectomies for muscle-invasive bladder cancer in patients with severe concomitant pathology who underwent transureteroureterostomy with unilateral ureterocutaneostomy for urine derivation.

 Results. It was shown that this intervention does not have high morbidity, does not increase the incidence of early postoperative complications, and relieves patients from bilateral urostoma. Among late complications, inflammatory ones predominate due to obstruction of the external stent. The authors highlight the tactics and technical aspects of managing such patients with obstructive pyelonephritis and the experience of drainage-free management.

Conclusion. Transureteroureterostomy with unilateral ureterocutaneostomy after cystectomy for muscle-invasive bladder cancer can be considered as the operation of choice in patients with a burdened comorbidity.

About the Authors

S. V. Shkodkin
Belgorod Regional Clinical Hospital of Saint Joasaph; Belgorod National Research University, Ministry of Education and Science of Russia
Russian Federation

8 / 9 Nekrasova St., Belgorod 308007; 85 Pobedy St., Belgorod 308015

 



Yu. B. Idashkin
Belgorod Regional Clinical Hospital of Saint Joasaph
Russian Federation
8 / 9 Nekrasova St., Belgorod 308007


References

1. Ferlay J., Steliarova-Foucher E., LortetTieulent J. et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 2013;49(6):1374–403. DOI: 10.1016/j.ejca.2012.12.027.

2. Malignant tumors in Russia in 2014 (morbidity and mortality). Eds.: А.D. Kaprin, V.V. Starinskiy, G.V. Petrova. Moscow: MNIOI im. P.A. Gertsena – filial FGBU “NMIRTS radiologii” Minzdrava Rossii, 2016. 250 p. (In Russ.).

3. Nizamova R.S., Zimichev A.A., Kliment’eva M.S. et al. Aetiopathogenesis of bladder cancer and forecasting the probability of disease. Aspirantskiy vestnik Povolzh’ya = Postgraduate Bulletin of the Volga Region 2015;(5–6):102–7. (In Russ.).

4. Yafi F.A., Cury F.L., Kassouf W. Organsparing strategies in the management of invasive bladder cancer. Expert Rev Anticancer Ther 2009;9(12):1765–75. DOI: 10.1586/era.09.151.

5. Kitamura H., Masumori N., Tsukamoto T. Role of lymph node dissection in management of bladder cancer. Int J Clin Oncol 2011;16(3):179–85. DOI: 10.1007/s10147-011-0235-1.

6. Chou R. Treatment of muscle-invasive bladder cancer: a systematic review. Cancer 2016;122(6):842–51.

7. Van Rhijn B.W., Burger M., Lotan Y. et al. Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy. Eur Urol 2009;56(3):430–42. DOI: 10.1016/j.eururo.2009.06.028.

8. Petrov S.B., Levkovskii N.S., Korol V.D. et al. Radical cystectomy used as a surgical treatment of muscle-invasive bladder cancer. Prakticheskaya onkologiya = Practical Oncology 2003;4(4):225–30. (In Russ.).

9. Safiullin K.N., Kariakin O.B. Radical cystectomy in the treatment of non-muscleinvasive bladder cancer. Onkourologiya = Cancer Urology 2012;(2):40–4. (In Russ.).

10. Scarpato K.R., Morgans A.K., Moses K.A. Optimal management of muscle-invasive bladder cancer – a review. Res Rep Urol 2015;7:143–51. DOI: 10.2147/RRU.S73566.

11. Veskimäe E., Neuzillet Y., Rouanne M. et al. Systematic review of the oncological and functional outcomes of pelvic organpreserving radical cystectomy (RC) compared with standard RC in women who undergo curative surgery and orthotopic neobladder substitution for bladder cancer. BJU Int 2017;120(1): 12–24. DOI: 10.1111/bju.13819.

12. Patidar N., Yadav P., Sureka S.K. et al. An audit of early complications of radical cystectomy using Clavien–Dindo classification. Indian J Urol 2016;32(4):282–7. DOI: 10.4103/09701591.191244.

13. Kiss B., Burkhard F.C., Thalmann G.N. Open radical cystectomy: still the gold standard for muscle invasive bladder cancer. World J Urol 2016;34(1):33–9. DOI: 10.1007/s00345-015-1729-7.

14. Amini E., Djaladat H. Long-term complications of urinary diversion. Curr Opin Urol 2015;25(6):570–7. DOI: 10.1097/MOU.0000000000000222.

15. Tomaszewski J.J., Smaldone M.C. Perioperative strategies to reduce postoperative complications after radical cystectomy. Curr Urol Rep 2015;16(5):26. DOI: 10.1007/s11934-015-0503-0.

16. Aboumarzouk O.M., Hughes O., Narahari K. et al. Safety and feasibility of laparoscopic radical cystectomy for the treatment of bladder cancer. J Endourol 2013;27(9):1083–95. DOI: 10.1089/end.2013.0084.

17. Novara G., Catto J.W., Wilson T. et al. Systematic review and cumulative analysis of perioperative outcomes and complications after robot-assisted radical cystectomy. Eur Urol 2015;67(3): 376–401. DOI: 10.1016/j.eururo.2014.12.007.

18. Hautmann R.E., Abol-Enein H., Lee C.T. et al. Urinary diversion: how experts divert. Urology 2015;85(1):233–8. DOI: 10.1016/j.urology.2014.06.075.

19. Krajewski W., Zdrojowy R., Tupikowski K. et al. How to lower postoperative complications after radical cystectomy – a review. Cent European J Urol 2016;69(4):370–6. DOI: 10.5173/ceju.2016.880.

20. Kozacıoğlu Z., Değirmenci T., Günlüsoy B. et al. Ureterocutaneostomy: for whom and when? Turk J Urol 2013;39(3):143–6. DOI: 10.5152/tud.2013.030.

21. Higgins C. Transuretero-ureteral anastomosis. Report of a clinical case. J Urol 1935;34:349.

22. Deliveliotis C., Papatsoris A., Chrisofos M. et al. Urinary diversion in high-risk elderly patients: modified cutaneous ureterostomy or ileal conduit? Urology 2005;66(2):299–304. DOI: 10.1016/j.urology.2005.03.031.

23. Schulz G.B., Grimm T., Buchner A. et al. Surgical high-risk patients with ASA 3 undergoing radical cystectomy: morbidity, mortality, and predictors for major complications in a high-volume tertiary center. Clin Genitourin Cancer 2018;16(6):e1141–9. DOI: 10.1016/j.clgc.2018.07.022.

24. Barry J.M. Surgical atlas transureteroureterostomy. The Oregon Health & Science University, Portland, Oregon, USA, 2005. P. 7.

25. Frank J.D., Gearhart J.G., Snyder H.M. Operative pediatric urology. Churchill Livingstone, 2nd edn, 2001, 320 p.

26. Novick A.C., Jones J.S., Gill I.S. et al. Operative urology at the cleveland clinic. Totowa: Humana Press, 2006. 540 p.


Review

For citations:


Shkodkin S.V., Idashkin Yu.B. Choice of urine derivation method after radical cystectomy in the high anesthesiological risk group. Cancer Urology. 2020;16(1):90-98. (In Russ.) https://doi.org/10.17650/1726-9776-2020-16-1-90-98

Views: 1870


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1726-9776 (Print)
ISSN 1996-1812 (Online)
X